Scimago Lab
powered by Scopus
call: +1.631.629.4327
Mon-Fri 10 am - 2 pm EST


Medical Science Monitor Basic Research


eISSN: 2329-0358

Home Page

Annals of Transplantation is one of the fast-developing journals open to all scientists and fields of transplant medicine and related research. The journal is published quarterly and provides extensive coverage of the most important advances in transplantation.
Using an electronic on-line submission and peer review tracking system, Annals of Transplantation is committed to rapid review and publication. The average time... read more

Published: 2020-10-27



Prognosis and Treatment of Liver Transplant Recipients in the COVID-19 Era: A Literature Review

Ashraf Imam, Sadi A. Abukhalaf, Hadar Merhav, Samir Abu-Gazala, Oded Cohen-Arazi, Alon Josef Pikarsky, Rifaat Safadi, Abed Khalaileh

Transplantation Unit, Department of Surgery, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

Ann Transplant 2020; 25:e926196

DOI: 10.12659/AOT.926196

ABSTRACT: Liver transplantation during the COVID-19 pandemic is challenging. Both donor and recipient issues can be influenced by the risks attributed to the pandemic. Allocation policy may need to be modified and criteria may be influenced by local infection rates and availability of medical facilities. Modifying immunosuppression (IS) protocols is controversial and is not evidence-based. In this study, we review the published literature on liver transplant recipients who were infected with COVID-19.
A literature review was performed using PubMed, ScienceDirect, and WHO databases to identify relevant English-language articles published up to May 20, 2020.
Fifteen articles reported 120 liver transplant recipients who were infected with COVID-19. Only 10 papers with 22 patients reported full encounter characteristics. Four papers reported 23, 17, 13, and 6 patients, respectively, but with minimal data. One paper reported the authors’ own 39 patients’ characteristics and demographics. The mean age was 58.2 years with 66% males. The most commonly reported presentations in descending order were fever (91%), cough (36.7%), shortness of breath (SOB) (31.8%), and diarrhea (31.8%). Liver transplant patients infected with COVID-19 were maintained on Tac (79%), mycophenolate (MMF) (48.4%), and Prednisone (29.6%) and were managed by reducing MMF in 14.3% of patients and reducing Tac in 14.3% of patients; 28.6% of patients needed ICU admission, 13.6% of patients had died, and the reported general population COVID-19 mortality rate was 3.4%.
The clinical presentation of COVID-19 in liver transplant recipients may be different from the general population, with higher rates of severe disease, complications, and mortality.

Keywords: COVID-19, Liver Transplantation, Organ Transplantation, SARS Virus

Published: 2020-10-23


Transplant Radical Nephrectomy and Transplant Radical Nephroureterectomy for Renal Cancer: Postoperative ...

Department of Urology, Emory University School of Medicine, Atlanta, GA, USA

Reza Nabavizadeh, Anika A. Noorali, Salima S. Makhani, Gordon Hong, Sarah Holzman, Dattatraya H. Patil, Frances Y. Kim, Paul L. Tso, Nicole A. Turgeon, Kenneth Ogan, Viraj A. Master

Ann Transplant 2020; 25:e925865

DOI: 10.12659/AOT.925865

Published: 2020-10-20


Clinical Relevance of Kidney Biopsy in Patients Qualified for Liver Transplantation and After This Proced...

Department of Nephrology, Dialysis, and Internal Disease, Medical University of Warsaw, Warsaw, Poland

Monika Wieliczko, Urszula Ołdakowska-Jedynak, Jolanta Małyszko

Ann Transplant 2020; 25:e925891

DOI: 10.12659/AOT.925891